| Digit recall — B-Lit | On the Digit Span test of digit sequence recall, scores rose by an average of 2.45 points with B-Lit and 0.17 points with placebo over 84 days. The difference in change was 2.28 points. | 2/4 LowRisk of bias. The analysis included only participants who completed the study. Several participants dropped out. The researchers assessed many outcomes. Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The study measured performance on specific tests. It did not measure overall performance at school, at work, or in everyday activities. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished. | 1randomized trialEffect of Bacopa monnieri Extract on Memory and Cognitive Skills in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Study ↗ | Healthy adults aged 18–55 without sleep disorders. 80 were assigned to groups and 74 completed the study (38 in the B-Lit group and 36 in the placebo group). | - Effect of Bacopa monnieri Extract on Memory and Cognitive Skills in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Study ↗
|
|---|
| Delayed word recall in older adults | After 12 weeks, participants recalled an average of 7.6 words after a delay, up from 6.4 at baseline with bacopa, and 6.9 words, up from 6.8 with placebo. The paper tested changes statistically within each group and did not report a separate estimate of the difference in change between groups. | 2/4 LowRisk of bias. The study was small, with 48 of 54 participants completing it. For this outcome, the authors tested change within each group, limiting what can be concluded about a benefit over placebo. Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The study measured performance on specific tests. It did not measure overall performance at school, at work, or in everyday activities. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished. | 1randomized trialEffects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial ↗ | Independently living adults aged 65 and older without dementia or memory complaints. 54 were assigned to groups and 48 completed the study (24 per group). | - Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial ↗
|
|---|
| Word learning and recall — Bacumen | On the primary test of word learning and recall, Bacumen showed no benefit over placebo after 12 weeks (p=0.391). | 2/4 LowRisk of bias. The analysis included the 87 of 101 participants who completed the study. Dropout differed between groups (10 with Bacumen and 4 with placebo). Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The study measured performance on specific tests. It did not measure overall performance at school, at work, or in everyday activities. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished. | 1randomized trialThe Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial ↗ | Adults aged 40–70 with memory and attention complaints. 101 were assigned to groups and 87 completed the study (40 in the Bacumen group and 47 in the placebo group). | - The Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial ↗
- An examination into the effects of a Bacopa monnieri extract (Bacumen) on cognition and stress in healthy adults with subjective memory complaints: a randomised, double-blind, placebo-controlled trial — ANZCTR ACTRN12623000475640 ↗
|
|---|
| Attention — Bacumen | On the primary attention test, Bacumen showed no benefit over placebo after 12 weeks (p=0.713). | 2/4 LowRisk of bias. The analysis included the 87 of 101 participants who completed the study. Dropout differed between groups (10 with Bacumen and 4 with placebo). Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The study measured performance on specific tests. It did not measure overall performance at school, at work, or in everyday activities. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished. | 1randomized trialThe Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial ↗ | Adults aged 40–70 with memory and attention complaints. 101 were assigned to groups and 87 completed the study (40 in the Bacumen group and 47 in the placebo group). | - The Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial ↗
- An examination into the effects of a Bacopa monnieri extract (Bacumen) on cognition and stress in healthy adults with subjective memory complaints: a randomised, double-blind, placebo-controlled trial — ANZCTR ACTRN12623000475640 ↗
|
|---|
| Performance on a task with distracting information in older adults | On the Stroop test, reaction time decreased from 60.1 to 57.2 seconds with bacopa and from 60.9 to 60.5 seconds with placebo. A shorter time means faster performance on the task with distracting information. The statistical test in the paper assessed change within the group. | 2/4 LowRisk of bias. The study was small, with 48 of 54 participants completing it. For this outcome, the authors tested change within each group, limiting what can be concluded about a benefit over placebo. Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The study measured performance on specific tests. It did not measure overall performance at school, at work, or in everyday activities. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished. | 1randomized trialEffects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial ↗ | Independently living adults aged 65 and older without dementia or memory complaints. 54 were assigned to groups and 48 completed the study (24 per group). | - Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial ↗
|
|---|
| Perceived stress — B-Lit | Over 84 days, the PSS-10 perceived stress score decreased by an average of 6.30 points with B-Lit and 0.38 points with placebo. The difference in change was 5.92 points in favor of B-Lit. | 2/4 LowRisk of bias. The analysis included only participants who completed the study. Several participants dropped out. The researchers assessed many outcomes. Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The result applies to the specified extract, population, and task. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished. | 1randomized trialEfficacy and Safety of Bacopa monnieri Extract for Stress Management and Sleep Quality: A Randomized, Double-Blind, Placebo-Controlled Trial ↗ | Adults aged 18–60 who had experienced stress for no more than 12 weeks and had no psychiatric diagnosis. 50 were assigned to groups and 44 completed the study (23 in the B-Lit group and 21 in the placebo group). | - Efficacy and Safety of Bacopa monnieri Extract for Stress Management and Sleep Quality: A Randomized, Double-Blind, Placebo-Controlled Trial ↗
|
|---|
| Overall stress reactivity — Bacumen | Over 12 weeks, participants taking Bacumen reported a greater decrease in overall stress reactivity than those taking placebo (p=0.03). This result came from the Perceived Stress Reactivity Scale questionnaire, which was separate from the assessment of responses to computer tasks. | 2/4 LowRisk of bias. The analysis included the 87 of 101 participants who completed the study. Dropout differed between groups (10 with Bacumen and 4 with placebo). Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. Overall stress reactivity was measured by questionnaire in people with memory and attention complaints. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished. | 1randomized trialThe Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial ↗ | Adults aged 40–70 with memory and attention complaints. 101 were assigned to groups and 87 completed the study (40 in the Bacumen group and 47 in the placebo group). | - The Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial ↗
- An examination into the effects of a Bacopa monnieri extract (Bacumen) on cognition and stress in healthy adults with subjective memory complaints: a randomised, double-blind, placebo-controlled trial — ANZCTR ACTRN12623000475640 ↗
|
|---|
| Fatigue after mental tasks — Bacumen | The authors reported less fatigue after a series of mental tasks with Bacumen. In the published graph, mental fatigue immediately after a computer task at week 12 was about 28 points with Bacumen and 33 with placebo, compared with about 30 and 27 points, respectively, before treatment. The values are rounded estimates from the graph. | 2/4 LowRisk of bias. The analysis included the 87 of 101 participants who completed the study. Dropout differed between groups (10 with Bacumen and 4 with placebo). Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. Researchers measured fatigue after a series of mental tasks in people with memory and attention complaints. The result does not describe alertness throughout the day. Precision. The sample was small, limiting the precision of the between-group difference. The means shown are rounded estimates from the graph. They were not taken from a table of numerical results. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished. | 1randomized trialThe Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial ↗ | Adults aged 40–70 with memory and attention complaints. 101 were assigned to groups and 87 completed the study (40 in the Bacumen group and 47 in the placebo group). | - The Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial ↗
- An examination into the effects of a Bacopa monnieri extract (Bacumen) on cognition and stress in healthy adults with subjective memory complaints: a randomised, double-blind, placebo-controlled trial — ANZCTR ACTRN12623000475640 ↗
|
|---|
| Emotional well-being — B-Lit | The POMS-40 negative mood score decreased over 84 days by an average of 13.13 points with B-Lit and 1.76 points with placebo. The difference in change was 11.37 points. A lower score indicates better emotional well-being. | 2/4 LowRisk of bias. The analysis included only participants who completed the study. Several participants dropped out. The researchers assessed many outcomes. Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The result applies to the specified extract, population, and task. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished. | 1randomized trialEfficacy and Safety of Bacopa monnieri Extract for Stress Management and Sleep Quality: A Randomized, Double-Blind, Placebo-Controlled Trial ↗ | Adults aged 18–60 who had experienced stress for no more than 12 weeks and had no psychiatric diagnosis. 50 were assigned to groups and 44 completed the study (23 in the B-Lit group and 21 in the placebo group). | - Efficacy and Safety of Bacopa monnieri Extract for Stress Management and Sleep Quality: A Randomized, Double-Blind, Placebo-Controlled Trial ↗
|
|---|
| Emotional well-being — Bacognize | The SF-36 emotional well-being score rose from 69.32 to 79.20 points with Bacognize and from 71.78 to 75.67 with placebo. Scores improved by 9.88 and 3.89 points, respectively. The difference in change was 5.99 points (p=0.016). | 2/4 LowRisk of bias. Final questionnaires were missing for 11 of 100 participants. Emotional well-being was an additional outcome. The primary sleep outcome showed no advantage. Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The result applies to the specified extract, population, and task. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished. | 1randomized trialEffects of a Bacopa monnieri extract (Bacognize®) on stress, fatigue, quality of life and sleep in adults with self-reported poor sleep: A randomised, double-blind, placebo-controlled study ↗ | Physically healthy adults aged 18–70 with complaints of poor sleep. 100 were assigned to groups and 89 returned the final questionnaires (44 in the Bacognize group and 45 in the placebo group). | - Effects of a Bacopa monnieri extract (Bacognize®) on stress, fatigue, quality of life and sleep in adults with self-reported poor sleep: A randomised, double-blind, placebo-controlled study ↗
|
|---|
| Sleep in adults experiencing stress — B-Lit | The PSQI sleep problem score decreased over 84 days by an average of 3.70 points with B-Lit and 0.52 points with placebo. The difference in change was 3.18 points. A lower score indicates better sleep. | 2/4 LowRisk of bias. The analysis included only participants who completed the study. Several participants dropped out. The researchers assessed many outcomes. Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The result applies to the specified extract, population, and task. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished. | 1randomized trialEfficacy and Safety of Bacopa monnieri Extract for Stress Management and Sleep Quality: A Randomized, Double-Blind, Placebo-Controlled Trial ↗ | Adults aged 18–60 who had experienced stress for no more than 12 weeks and had no psychiatric diagnosis. 50 were assigned to groups and 44 completed the study (23 in the B-Lit group and 21 in the placebo group). | - Efficacy and Safety of Bacopa monnieri Extract for Stress Management and Sleep Quality: A Randomized, Double-Blind, Placebo-Controlled Trial ↗
|
|---|
| Sleep in adults with insomnia complaints — Bacognize | By day 27, scores on the BIS insomnia questionnaire decreased from 27.77 to 13.89 points with Bacognize and from 28.18 to 14.98 with placebo. Sleep improved in both groups, with no advantage detected for Bacognize. | 2/4 LowRisk of bias. Final questionnaires were missing for 11 of 100 participants. Emotional well-being was an additional outcome. The primary sleep outcome showed no advantage. Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The result applies to the specified extract, population, and task. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished. | 1randomized trialEffects of a Bacopa monnieri extract (Bacognize®) on stress, fatigue, quality of life and sleep in adults with self-reported poor sleep: A randomised, double-blind, placebo-controlled study ↗ | Physically healthy adults aged 18–70 with complaints of poor sleep. 100 were assigned to groups and 89 returned the final questionnaires (44 in the Bacognize group and 45 in the placebo group). | - Effects of a Bacopa monnieri extract (Bacognize®) on stress, fatigue, quality of life and sleep in adults with self-reported poor sleep: A randomised, double-blind, placebo-controlled study ↗
|
|---|
| Sleep scores in adults without sleep disorders — B-Lit | In adults without sleep disorders, the PSQI score decreased over 84 days by an average of 1.71 points with B-Lit and 0.06 points with placebo. The difference in change was 1.65 points. A lower score indicates better sleep. | 2/4 LowRisk of bias. The analysis included only participants who completed the study. Several participants dropped out. The researchers assessed many outcomes. Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The study excluded people with sleep disorders. This result describes sleep scores in participants who were healthy at baseline. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished. | 1randomized trialEffect of Bacopa monnieri Extract on Memory and Cognitive Skills in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Study ↗ | Healthy adults aged 18–55 without sleep disorders. 80 were assigned to groups and 74 completed the study (38 in the B-Lit group and 36 in the placebo group). | - Effect of Bacopa monnieri Extract on Memory and Cognitive Skills in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Study ↗
|
|---|